CD44 and infection: The protective potential of MIC1 and MIC4 is evidenced by studies utilizing these proteins as experimental vaccines in mice, demonstrating that vaccinated animals had a significantly reduced brain cyst burden and lower mortality rates compared to unvaccinated controls following infection [20,21].